SomnoMed Ltd

RJV

Company Profile

  • Business description

    SomnoMed Ltd provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is engaged in commercializing SomnoDent Mandibular Advancement Splint (MAS) and other oral devices for sleep-related disorders in Australia and overseas. The other products in the company's portfolio include SomMorning Repositioner; SomnoBrux splint, a custom-fit, acrylic splint (dental guard) for upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs cleaning tablets that have been developed to clean oral appliances. Geographically, the company generates maximum revenue from Europe, followed by North America and the Asia Pacific region.

  • Contact

    20 Clarke Street
    Level 3
    Crows Nest
    SydneyNSW2065
    AUS

    T: +61 294670400

    https://www.somnomed.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 June 2026

    Employees

    22

Stocks News & Analysis

stocks

Overpriced ASX listed consumer electronics retailers

Solid balance sheets, lower business risk and strong sales but investors are overly optimistic.
stocks

Nvidia and AMD: Maintain fair value estimate amid reports of Meta’s negotiations to buy Google TPUs

Our update on select stocks from the Semiconductors industry.
stocks

Alphabet: Gemini momentum and possible Meta TPU deal underscore AI capability

We think Alphabet is exceptionally well positioned in everything AI.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,912.002.900.03%
CAC 408,096.4370.630.88%
DAX 4023,726.22261.591.11%
Dow JONES (US)47,427.12314.670.67%
FTSE 1009,691.5882.050.85%
HKSE25,940.2212.140.05%
NASDAQ23,214.69189.100.82%
Nikkei 22550,167.10608.031.23%
NZX 50 Index13,432.20129.81-0.96%
S&P 5006,812.6146.730.69%
S&P/ASX 2008,617.302.400.03%
SSE Composite Index3,875.2611.080.29%

Market Movers